The public issue is entirely an offer-for-sale (OFS) of up to 21.7 million shares by the promoters and other shareholders to the tune of around ₹1,800 crore, said bankers. The company operates under the “Blue Jet” brand offering niche products targeted at innovator pharmaceutical companies and multinational generic pharmaceutical companies.
Vijay Kedia slashes stakes in these 5 stocks during March quarter
Vijay Kedia publicly holds 17 stocks with a net worth of over Rs 1,664 crore, as per the latest corporate shareholding data.